A detailed history of Simplex Trading, LLC transactions in Biodesix Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 860 shares of BDSX stock, worth $1,453. This represents 0.0% of its overall portfolio holdings.

Number of Shares
860
Previous 1,071 19.7%
Holding current value
$1,453
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$1.21 - $1.71 $255 - $360
-211 Reduced 19.7%
860 $1,000
Q1 2024

Apr 25, 2024

BUY
$1.35 - $2.12 $1,445 - $2,270
1,071 New
1,071 $1,000
Q2 2023

Aug 04, 2023

BUY
$1.12 - $1.88 $106 - $178
95 New
95 $0
Q4 2022

Feb 02, 2023

BUY
$0.98 - $2.3 $2,160 - $5,071
2,205 Added 841.6%
2,467 $5,000
Q3 2022

Nov 04, 2022

BUY
$1.24 - $2.89 $324 - $757
262 New
262 $0
Q2 2022

Aug 03, 2022

SELL
$1.32 - $2.12 $143 - $231
-109 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$1.69 - $5.81 $101 - $348
60 Added 122.45%
109 $0
Q4 2021

Feb 23, 2022

BUY
$4.09 - $8.67 $200 - $424
49 New
49 $0

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $67.6M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.